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494a Tuesday, March 8, 2011in contrast to greater than 10 minutes after the 254 nm UV exposure. When
a different dye: calcein-blue (Ex/Em 360/460 nm) was encapsulated in the li-
posomes, the 514 nm laser exposure treatments did not release the calcein-
blue dye suggesting the release mechanism to be wavelength specific. The
514 nm laser treatment on calcein loaded liposomes did not result in any mea-
surable chemical changes in the lipids as determined by LC-MS and morpho-
logical changes in the liposomes as determined by Cryo electron microscopy.
The 514 nm treatment of calcein-loaded liposomes also resulted in the produc-
tion of reactive oxygen species as determined through ROS assays. Moreover,
the laser-induced release of calcein was inhibited in the presence of oxygen rad-
ical scavengers. Based on these observations, we propose that visible-light trig-
gered release of entrapped solutes from DPPC/DC8,9PC liposomes occurs via
a novel mechanism that involves photo-sensitizer-generated reactive oxygen
species to perturb DC8,9PC in the liposome membrane. These formulations
are currently under investigations for drug delivery/release applications.
Membrane Active Peptides II
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On the Origin of Multi-Exponential Kinetics in Peptide Binding to Phos-
pholipid Vesicles
Alex Kreutzberger, Antje Pokorny.
Binding kinetics of amphipathic peptides to phospholipid bilayer vesicles are
generally well described by a single exponential function. However, closer in-
spection of the data sometimes reveals the presence of additional exponential
phases. These usually depend on the exact experimental conditions and on the
peptide studied, but are indicative of other processes that contribute to the bind-
ing kinetics. We investigated the binding of a model amphipathic peptide,
Lysette-26, to unilamellar lipid vesicles composed of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) as a function of lipid and peptide concentra-
tion. Lysette-26 is a 22 residue peptide with the sequence IISTIGDLVK
WIIDTVKWIIDTVNKFTKK. The peptide binds well to zwitterionic lipid
bilayer membranes and forms an amphipathic a-helix when bound at the
membrane-water interface. Peptide binding was measured through fluorescence
energy transfer from the intrinsic tryptophan residue in the peptide to an acceptor
fluorophore embedded in the membrane at low concentrations. A series of exact
kinetic models was developed to describe the experimental data. We found that
the kinetics of peptide binding to POPC vesicles depended strongly on peptide
concentration in solution. The model that best described the experimental data
included the presence of peptide monomers and aggregates in solution that
bind independently andwith different rate constants to the lipid vesicles. Peptide
aggregation is favored at higher peptide concentrations, leading to the appear-
ance of an additional exponential phase. Based on the kinetic models, other pro-
cesses, such as peptide insertion or translocation across the bilayer, could be
excluded as the source of the second exponential phase in the binding kinetics.
2684-Pos Board B670
Peptides with Multiple Arginines can Spontaneously Translocate across
Lipid Vesicle Membranes and across Living Cell Membranes
Jessica R. Marks, Kalina Hristova, William C. Wimley.
Using orthogonal high-throughput screening and rational combinatorial peptide
libraries, we have identified a family of peptides that appear to spontaneously
translocate across membranes without any membrane permeabilization. The
conserved 9-residue translocation motif is mostly hydrophobic, composed of
leucine, isoleucine and proline, but also has several conserved arginine or ly-
sine residues and an open terminal amino group. Using confocal fluorescence
microscopy, we tested the ability of the selected peptides to transport a large
polar dye, TAMRA, across anionic PC/PG (90:10) vesicles and across zwitter-
ionic PC vesicles. To increase the stringency of the experiment, multilamellar
vesicles were used such that the peptides had to sequentially pass through 10-15
bilayers in order to equilibrate into the interior of the vesicles. The peptides
identified in the screen rapidly and completely equilibrated across vesicles of
either composition within about 15 minutes of addition. Binding of the peptides
to the vesicles was weak, suggesting that the small number of peptides bound at
any moment in time translocate extremely efficiently. A 3000 Da fluorescent
dextran was excluded from the vesicles, even in the presence of rapidly trans-
locating peptides. The same dye-labeled peptides also rapidly translocate
across the plasma membranes of living cells, filling the cytoplasm with a uni-
form fluorescence. Translocation was rapid, and no evidence of toxicity was
observed. We show that translocation across plasma membranes is spontane-
ous, and that endocytosis is not involved in cell penetration for these peptides.
Despite the presence of multiple arginine residues, the peptide family identified
in the orthogonal high-throughput screen rapidly translocates across synthetic
membranes and living cell membranes with a large polar dye attached. These
peptides could be used as delivery vehicles for a variety of polar drugs.2685-Pos Board B671
Characterizing the Antibacterial Mechanism of Three Novel Histone-
Derived Antimicrobial Peptides
Sara A. Spinella, SeiEun Chun, Kathryn E. Pavia, Andrew C. Webb,
Donald E. Elmore.
The rise in antibiotic resistant pathogens has sparked interest in antimicrobial
peptides (AMPs), especially those that are active against a wide variety of bac-
terial strains. Cell penetrating AMPs are of particular importance for their po-
tential as both drug delivery systems and antimicrobial agents. Buforin II (BF2)
is a well-characterized antimicrobial peptide derived from histone subunit H2A
that kills bacteria by translocating across cell membranes and binding to nu-
cleic acids. In this study, we compared the mechanisms of action of three novel
histone-derived antimicrobial peptides (HDAPs), termed DesHDAP1-3, to that
of BF2. DesHDAP1’s antibacterial potency is similar to that of BF2 across sev-
eral bacterial species, while DesHDAP2 and DesHDAP3 are generally weaker
antibacterial agents. Our current data also implies that DesHDAP1 shows in-
creased cytotoxicity against cancerous cells lines compared to BF2. Lipid ves-
icle studies measuring the translocation of all three designed peptides showed
that DesHDAP2 does not cross lipid membranes as readily as DesHDAP1,
DesHDAP3, or BF2, which may explain its poor antibacterial activity. For
comparison, we have also considered the membrane permeabilization caused
by the designed peptides using a propidium iodide uptake assay. Finally, we
have considered the role of nucleic acid binding in the mechanism of the de-
signed peptides by measuring the DNA binding and antimicrobial activity of
mutant versions of the designed peptides. This data shows that all three peptides
may not show the same correlation between DNA binding and activity ob-
served for BF2. An understanding of how the designed peptides function is
an important step in assessing their therapeutic potential and considering future
design strategies.
2686-Pos Board B672
Cell Penetrating Peptides. How do they Cross Membranes?
Joachim Seelig, Andre´ Ziegler, Gabriela Klocek.
Cell penetrating peptides (CPPs) are cationic peptides which, when linked to
proteins, genes, or nanoparticles, facilitate the transport of these entities across
the cell membrane. Different models have been suggested for their mode of ac-
tion. One possibility is the binding of CPPs to negatively charged lipids and the
formation of non-bilayer structures. We have studied the binding of two CPPs
(R9, HIV-1 TAT) to model membranes with isothermal titration calorimetry
and observe indeed a strong binding to the membrane. However, the bilayer re-
mains intact and non-bilayer structures can be excluded based on 2H- and 31P-
NMR spectroscopy. A second mechanism is the binding of CPPs to sulfated
sugars at the membrane surface, followed by endocytosis. We have character-
ized the binding of a large variety of CPPs to heparin sulfate (HS), heparin, and
related sulfated glycosaminoglycans (GAGs) and find binding constants in the
order of 106 - 107 M1 per binding site. An even stronger interaction is found
between CPPs and DNA with binding constants in 107 - 108 M1. We have fur-
ther synthesized a fluorescent derivative of the HIV-1 TAT protein transduction
domain (Fg-CPPTAT(PTD)) and have observed its uptake into non-fixated living
fibroblasts with time-lapse confocal microscopy. We find that Fg-CPPTAT(PTD)
enters the cytoplasm and nucleus of non-fixated fibroblasts within seconds.
With differential interference contrast microscopy we furthermore detect dense
aggregates on the cell surface. Several observations suggest that these aggre-
gates consist of Fg-CPPTAT(PTD) bound to membrane-associated heparan sul-
fate (HS). Finally a pore-forming peptide, melittin, also binds to sulfated
GAGs but not magainin 2 or nisin Z. The binding of the melittin to lipid bila-
yers is furthermore an excellent model system to elucidate the thermodynamic
parameters of membrane-induced a-helix and b-sheet formation.
.
2687-Pos Board B673
AFM Force Spectroscopy on TAT Membrane Penetration
Elizabeth A. Hager-Barnard, Benjamin D. Almquist, Nicholas A. Melosh.
We present a combined experimental and theoretical study of the interactions
between cell-penetrating peptides (CPPs) and lipid bilayers using dynamic
AFM measurements. Understanding how CPPs can pass through cell mem-
branes is critical for designing drug delivery agents. While CPPs like HIV-
TAT have been widely studied, their ability to penetrate membranes directly,
without active transport, is still a matter of considerable debate. Here, we di-
rectly measure TAT-lipid mechanics during the actual membrane translocation
event using TAT-functionalized AFM probes to penetrate through a stack of
lipid bilayers. Dynamic force spectroscopy revealed that both the bilayer break-
through force and bilayer thickness depended on the TAT-bilayer contact time.
The results provide a detailed view of how TAT interacts with the bilayer.
Upon contact, TAT inserts into the bilayer headgroup to a depth of ~1nm in
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reflecting TAT-driven reorganization. Unexpectedly, the energy barrier for
penetration actually increases 52 kT after the bilayer thins, indicating the
new conformation has not weakened the bilayer and suggesting TAT cannot
penetrate unassisted. Controls with polylysine or mercaptoundecanoic acid
do not show this thinning behavior, implying the unique TAT-lipid interactions
play a significant role. This approach can be further generalized to the interac-
tion of a variety of peptides or membrane-active molecules with lipid bilayers.
Theoretical modeling of dynamic force spectroscopy measurements shows dis-
tinct features related to the timescale and disruption of lipid membranes upon
contact with a molecular species. By adapting existing AFM protocols to look
for these features it will be possible to directly characterize, with microsecond
resolution, the dynamics and energetics of the interactions between lipid bila-
yers and a wide range of peptides and molecular species.
2688-Pos Board B674
IR Spectroscopy of Protein and Peptide-Membrane Interactions: In Situ
Strategies for Tracking Fusion, Remodelling, and Refolding
Jessica Li, Michael W. Wong, Lauren Lin, Vanessa Bianchi,
Michelle Edwards, Christopher M. Yip.
Attenuated total reflection-infrared spectroscopy is a powerful technique for
characterizing protein and peptide-membrane interactions. Using a real-time,
flow-through design and a single bounce diamond ATR element, we have ex-
amined how three different families of proteins interact with model supported
lipid bilayers. These include (1) a lipid-remodelling protein from the saposin
family; (2) the dynamin-related GTP-ase Mgm1p; (3) a series of model mem-
branolytic peptides designed to adopt a helical motif in bacterial membranes.
Our studies provided compelling evidence of the action of these proteins, in-
cluding membrane remodeling, GTP-ase activity, and peptide aggregation.
We will describe the integration of laser-based fluorescence spectroscopy
with ATR-IR, which, when coupled with correlated in situ atomic force micros-
copy, will afford a uniquely capable multimodal imaging and characterization
platform.
2689-Pos Board B675
rBPI21 Causes (HEMI)Fusion and Leakage of Membranes and Promotes
Massive Lipopolysaccharide Aggregation
Marco Domingues, Miguel Castanho, Nuno C. Santos.
Bacteria are infectious agents that seem to have difficulties in acquiring resis-
tance against natural occurring antimicrobial peptides (AMPs). These posi-
tively charged polypeptides were then developed as an alternative to
conventional therapy against bacterial infections. rBPI21 is a 21 kDa peptide
based on the N-terminal region of the neutrophil bactericidal/permeability-
increasing protein (BPI). It has bactericidal effects on Gram-negative bacteria
and higher affinity for lipopolysaccharide (LPS), neutralizing its effect. rBPI21
is in phase III clinical trials against meningitis. This work aimed at elucidating
the mechanism of action of rBPI21 at the molecular level. We demonstrate that
rBPI21 promotes the aggregation of negatively charged large unilamellar vesi-
cles (LUV) and LPS aggregates, by dynamic light scattering, while for zwitter-
ionic phosphatidylcholine (POPC) LUV the size remains unchanged. The
aggregation increases with peptide concentration until promotion of massive
aggregation followed by sample flocculation/precipitation [1,2]. Through a Fo¨r-
ster resonance energy transfer (FRET) assay, the aggregation is followed by
(hemi)fusion of the negatively charged vesicles, culminating at their leakage
(also assessed by fluorescence spectroscopy). With the rBPI21-lipid interaction,
there is a progressive change in the zeta-potential of the LUV systems and LPS
aggregates [2]. LUV systems composed of phosphatidylglycerol (POPG) and
POPC:POPG mixtures have higher zeta-potential variations than POPC
LUV. For the LPS aggregates, rBPI21 neutralizes the surface charge and, at
higher peptide concentrations, overcompensates it [2]. The results demonstrate
that rBPI21 mechanism of action at the molecular level involves the interaction
with the LPS of the outer membrane of Gram-negative bacteria, followed by
internalization and leakage induction through the (hemi)fusion of the bacterial
outer and inner membranes, both enriched in phosphatidylglycerol.
[1] Domingues, MM et al., Biophys. J. 2009, 96, 987-996.
[2] Domingues, MM et al., PLoS ONE 2009, 4, e8385.
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Significance of Stereochemistry in Short Antimicrobial Peptides
Virginia F. Smith, Barney M. Bishop, E. Andrew Papanastasiou,
Myra Jehangir, Hannah Choi, Monique L. van Hoek.
Cationic antimicrobial peptides (CAMPs) are essential elements of immunity in
higher organisms. These peptides are capable of exerting a direct antimicrobial
effect through a process that appears to at least in part involve interaction be-tween the peptides and the bacterial membrane, which ultimately leads to mem-
brane disruption. The lipids and other components that comprise cellular
membranes contain chiral centers with defined stereochemistry that CAMPs
may encounter as they interact with the membrane. The significance of mem-
brane and peptide chirality is not well defined. Helical CAMPs provide an at-
tractive tool for addressing these questions. They adopt a helical conformation
when they interact with bacterial membranes, but in the absence of the influ-
ence of negatively charged bacterial membranes, they assume a relatively un-
structured random coil. Formation of an amphipathic helix is usually essential
to the antimicrobial mechanism employed by these peptides. Accordingly, we
have used a pair of short helical CAMP enantiomers, with sequences based on
that of the Naja atra cathelicidin, to study how peptide stereochemistry impacts
peptide-lipid interactions. We have employed several biophysical techniques to
characterize the interactions between chiral membranes and the D- and L-
forms of antimicrobial peptides, including circular dichroism to reveal the ef-
fect of membranes on peptide secondary structure and electron paramagnetic
resonance to assess the effect of peptides on spin-labeled lipids. The biophys-
ical studies are complemented by functional assays of the antimicrobial activ-
ities of each peptide.
2691-Pos Board B677
Interaction of Biologically-Relevant Peptides with Membrane Model
Systems
Luis G. Mansor Basso, Eduardo F. Vicente, Eduardo M. Cilli,
Antonio J. Costa-Filho.
In this work, we monitor the alterations caused in membrane model systems
upon the addition of biologically-relevant peptides. Our first study reports on
the interaction with model membranes of an internal fusion peptide (SARSIFP)
from the S2 subunit of the SARS coronavirus spike glycoprotein. It is believed
that SARSIFP might be fundamental for the later steps of the fusion between the
viral and host cellular membranes. Non-linear least-squares fits of stearic acid
spin labels ESR spectra showed that the rotational dynamics of the HPS head-
group region and of the whole carbon chain of SDS surfactants was perturbed
by the peptide. Additionally, Tyr fluorescence quenching promoted by spin la-
bels locates this residue in the aqueous interface of HPS and in the hydrophobic
core of SDS micelles. The second investigation deals with the conformational
changes induced by interactions with model membranes of three TOAC-
labeled peptide analogues derived from a new antimicrobial peptide extracted
from the skin secretion of the frog Hypsiboas albopunctatus. Our results shed
light on how the peptides labeled at positions 0, 2, and 13 interact with DPPC/
DPPA/X (X = DPPE, SM, and CL) liposomes and LPC micelles. The findings
allowed the description of the peptide topology into the membrane, where the
N-terminal region is solvent-exposed, position 2 is at the interface, and position
13 is fully inserted. Financial Support: FAPESP, CNPq, CAPES.
2692-Pos Board B678
Structure-Function Relationship Investigations of Neuropeptide Y Bound
to Hydrated Lipid Bilayers
Nathan A. Schneck, Courtney M. Carroll, Jack Blazyk, Myriam L. Cotten.
Neuropeptide Y (NPY) is a neuroendocrinic peptide which belongs to the neu-
ropeptide Y family. It activates Y-receptors, which are G-protein coupled re-
ceptors (GPCRs), and regulates various physiological processes.
Furthermore, NPY and some of its fragments have antimicrobial and immuno-
chemical properties. Several biophysical studies of NPY in the presence of
model membranes indicate that it interacts strongly with various lipids. Nota-
bly, the structure of micelle-bound NPY has provided insights about how the
so-called membrane catalysis model of Schwyzer applies to NPY. This model
proposes that the membrane induces a ‘‘bio-active conformation’’ of the pep-
tide that has the required orientation to bind the receptor selectively.
Characterizing the structural features of NPY under physiologically relevant
conditions is important to better understand its multiple functions. Since vari-
ations in the lipid composition of biological membranes can have drastic effects
on the activity of NPY and its fragments, we have used a combination of solid-
state NMR techniques to probe these peptides under changing conditions. In or-
der to investigate the structure, dynamics, topology and depth of insertion of the
peptides in the membrane-bound state, we have incorporated the peptides in
various aligned lipid mixtures and collected 15N and 31P solid-state NMR
spectra from the peptides and lipids, respectively. Circular dichroism studies
have also been performed to assess the global structures of the peptides under
sample conditions mirroring the ones used for the NMR studies. Finally, we
have investigated the antimicrobial activity of the peptides on Gram-positive
and Gram-negative bacteria. The results of these studies could be significant
in understanding the modes of action of NPY as a multifunctional peptide ac-
tive at various bacterial and mammalian lipid membranes.
